| Tag | Content |
|---|
EnhancerAtlas ID | HS187-01728 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr1:161581860-161582950 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC TATTTACTGT TTCAAATAAA 60
ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA TGAAACAGCC TCCGACAGCT 120
CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT CCATTTTCCC TGGCGACTCT 180
TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT CAAGGTAGAC CCTGTGTCGG 240
CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG AATCCGACAC CCGGCGGATC 300
CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG GGACATGAGG AGTGCGGGGG 360
GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC AACTGCGGCT TTCTCTCTCG 420
GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT TCACCGCCCC 480
CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT CTCACCAATG GAGGGCTTAG 540
CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG AACGGTCGGG AAAGTCATAC 600
GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC CGGGGACGCG TTGGTGGTGT 660
AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT TCGATTCCCG GGTAACGAAA 720
CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT 780
ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT CGCTTCCTGT 840
CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA GGGATTAAAT TCTGATGGTT 900
CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG GGATCATTTC 960
AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT GCGAGGTTCA 1020
TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA TTCCCGGCCG AGGTCCTAGG 1080
CTAAGGTCCC 1090
|
